Skip to main content
OpenTrials

Clinical trial condition

Progesterone Receptor Positive

Explore clinical trials studying Progesterone Receptor Positive. Study availability and eligibility vary by location and protocol.

17 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Progesterone Receptor Positive trial results

Recruiting

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NCT03723928

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Elevated CA15-3 or CEA or CA27-29, Estrogen Receptor Positive, +3 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 723 locations
View Trial Details
Completed

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

NCT01750073

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
Locations
  • Nebraska Medicine-Bellevue Bellevue, Nebraska, United States
  • CHI Health Saint Francis Grand Island, Nebraska, United States
  • Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

NCT00785291

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Sparks Regional Medical Center Fort Smith, Arkansas, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
View all 704 locations
View Trial Details
Completed

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

NCT01275677

Conditions
Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +12 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1283 locations
View Trial Details
Completed

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

NCT03691493

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • Grady Health System Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Piedmont Hospital Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details
Completed

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

NCT02648477

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope Rancho Cucamonga Rancho Cucamonga, California, United States
View Trial Details
Completed

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

NCT02526498

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +18 more
Locations
  • Arizona Breast Cancer Gilbert, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • William Beaumont Hospital Research Institute Royal Oak, Michigan, United States
  • RWJBarnabas Health - Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States
View Trial Details
Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

NCT02152943

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details

Related conditions